 A community-based, open-label, cluster-randomised longitudinal study in which children are randomized according to village health worker catchment areas comparing the safety and effectiveness of repeated treatments with artemether-lumefantrine AL over a 3-year period in children 4-48 months to that of repeated treatment with dihydroartemisinin-piperaquine DHA-PPQ. 